Jaguar Health, Inc. / Fundamentals

    Income statement

    Net revenue
    €10.10M
    Cost of goods sold
    €1.84M
    Gross profit
    €8.26M
    SG&A expenses
    €23.12M
    R&D expenses
    €13.36M
    EBITDA
    -€33.71M
    D&A
    €1.50M
    EBIT
    -€28.18M
    Interest expenses
    €48.05K
    EBT
    -€35.53M
    Tax expenses
    -€113.26K
    Net income
    -€34.87M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €6.23M
    Changes in working capital
    €495.07K
    Operating cash flow
    -€23.75M
    Capex
    €170.74K
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€184.47K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €7.08M
    Debt repayment
    €63.49K
    Other financing cash flow
    €4.86M
    Net financing cash flow
    €12.00M
    Foreign exchange effects
    €27.46K
    Net change in cash
    -€11.88M
    Cash at end of period
    €1.89M
    Free cash flow
    -€23.58M

    Balance sheet

    Cash and cash equivalents
    €1.89M
    Cash and short-term investments
    €1.89M
    Total receivables
    €1.13M
    Inventory
    €9.20M
    Other current assets
    €11.72M
    Total current assets
    €23.94M
    Property, plant & equipment
    €1.35M
    Goodwill
    €0.00
    Intangible assets
    €15.05M
    Long-term investments
    €0.00
    Other non-current assets
    €1.06M
    Total non-current assets
    €17.47M
    Total assets
    €41.41M
    Accounts payable
    €5.68M
    Short-term debt
    €16.15M
    Other current liabilities
    €3.09M
    Total current liabilities
    €25.07M
    Long-term debt
    €10.04M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €10.44M
    Total liabilities
    €35.51M
    Common stock
    €0.00
    Retained earnings
    -€315.19M
    Other equity
    -€616.90K
    Total equity
    €5.90M
    Total liabilities and shareholders' equity
    €41.41M

    Company information

    Market capitalization
    €2.82M
    Employees
    49
    Enterprise Value
    €37.46M

    Company ratios

    Gross margin
    81.8% Much worse than peer group: 543,852,529,135,152,600.0%
    EBITDA margin
    -333.9% Much worse than peer group: 3,842,868,617,809,890,400.0%
    EBIT margin
    -279.1% Much worse than peer group: 3,273,130,064,324,423,000.0%
    EBT margin
    -351.9% Much worse than peer group: 1,024,424,665,411,268,000,000.0%
    Net margin
    -345.4% Much better than peer group: -867,740,817,354,384,600.0%
    ROE
    -590.8% Much worse than peer group: -453.5%
    ROA
    -84.2% Much better than peer group: -387.1%
    Asset turnover
    24.4% Much worse than peer group: 45.7%
    FCF margin
    -236.9% Much worse than peer group: 2,511,596,989,999,028,000.0%
    FCF yield
    -846.8%
    Efficiency ratio
    433.9%
    Net sales per employee
    €206.04K
    Net income per employee
    -€711.70K

    Notifications